Skip to content
The Nexus
BUSINESSAug 4 · 11:40 UTCWTOP DCWTOP Staff

Palvella Therapeutics: Q2 Earnings Snapshot

Palvella Therapeutics reported a second-quarter loss of $21.9 million, or $1.52 per share, missing Wall Street expectations of a $1.16 per share loss. The results were generated by Automated Insights using data from Zacks Investment Research.

Nexus surfaces and summarizes. The full story lives at the source.

Mentioned
Palvella Therapeutics, Inc.organizationZacks Investment ResearchorganizationAutomated InsightsorganizationWayneplacePennsylvaniaplacePVLAtopic
Spot something wrong with this article?Report a problem →
Forward this
Palvella Therapeutics: Q2 Earnings Snapshot · The Nexus